Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group. (Q51828321)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 February 2013

Language	Label	Description	Also known as
English	Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group.	scientific article published on 27 February 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23446093%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Impact of chemotherapy regimen and rituximab in adult Burkitt lymphoma: a retrospective population-based study from the Nordic Lymphoma Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23446093%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Burkitt lymphoma

0 references

1 reference

based on heuristic

inferred from title

adult Burkitt lymphoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Tove Wästerlid

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23446093%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

P N Brown

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23446093%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

O Hagberg

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23446093%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

H Hagberg

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23446093%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

L M Pedersen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23446093%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

F D'Amore

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23446093%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

M Jerkeman

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23446093%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

27 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23446093%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23446093%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23446093%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23446093%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1879-1886

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23446093%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT058

21 January 2018

Population based study of prognostic factors and treatment in adult Burkitt lymphoma: a Swedish Lymphoma Registry study.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT058

21 January 2018

Treatment advances in adult Burkitt lymphoma and leukemia

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT058

21 January 2018

Outcomes of patients with Burkitt lymphoma older than age 40 treated with intensive chemotherapeutic regimens

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT058

21 January 2018

Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT058

21 January 2018

A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT058

21 January 2018

Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT058

21 January 2018

Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT058

21 January 2018

Burkitt lymphoma in adults

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT058

21 January 2018

Adult Burkitt leukemia and lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT058

21 January 2018

Treatment of Burkitt's/Burkitt-like lymphoma in adolescents and adults: a 20-year experience from the Norwegian Radium Hospital with the use of three successive regimens

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT058

21 January 2018

Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT058

21 January 2018

High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT058

21 January 2018

High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adults

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT058

21 January 2018

Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT058

21 January 2018

Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT058

21 January 2018

Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT058

21 January 2018

Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable,

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT058

21 January 2018

Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT058

21 January 2018

R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT058

21 January 2018

Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT058

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51828321&oldid=1561098925"